Subtitle statusmaker of AI-powered ultrasound guidance software, has partnered with Heart rate health to provide virtual cardiovascular care.
As part of the partnership, Caption clinicians will perform ultrasounds where needed, including the patient’s home. Heartbeat’s virtual cardiologists will then interpret the results remotely and discuss the findings with the patient’s primary care providers.
The new product builds on previous work, in which Caption and Heartbeat performed echocardiograms in high-risk individuals to look for signs of heart failure. Companies will offer the new program as a value-based package to providers, payers, and value-based care organizations.
Caption CEO Steve Cashman said: “This is the ideal combination of patient-centric services that will open up access to potentially life-saving early heart disease detection and prevention. Heartbeat Health’s top-tier network of cardiologists and virtual care.”
“Whether it’s cardiovascular health care for patients with risk factors, emergency care for patients with non-urgent symptoms, or convenient monitoring to help patients avoid costly expenses and complex, we believe that our shared offering will have a profound impact on the quality and cost of cardiac care for millions of patients.”
TREND TO BIGGER
Caption has entered into several partnerships this year. In June, the company announced a collaborate with in-home provider Portamedic to deliver its AI-powered ultrasound in patient homes and other facilities. It’s also working with UK-based Ultromics to use its tools in conjunction with Ultromics’ EchoGo deep ultrasound analysis.
Its software can also be used in portable ultrasound machines Butterfly Network’s New Platform.
Founded in 2013, Subtitles’ tutorial tool received FDA De Novo . license in 2020. The company announced a Series B worth $53 million a year later. Meanwhile, Heartbeat increased 20 million dollars last year built on a $8.2 million Series A from 2020.
Another player in the AI-powered ultrasound space is ultrasound equipment maker Exo, which recently announced acquired AI developer Medo. The company plans to integrate AI tools into its platform so that more clinicians can capture and interpret images.
